SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

Abstract Background Starting in December 2019, the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confronts the world with an unprecedented challenge. With no vaccine or drug being currently available to control the pandemic spread, prevention and PCR (Po...

Full description

Bibliographic Details
Main Authors: Sebastian Marschner, Stefanie Corradini, Josefine Rauch, Richard Zacharias, Ana Sujic, Julia Mayerle, Raluca Petru, Béatrice Grabein, Oliver T. Keppler, Edwin Boelke, Claus Belka, Maximilian Niyazi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Radiation Oncology
Subjects:
SARS-CoV-2
COVID-19
Coronavirus
Radiation oncology
Radiotherapy
Screening
Online Access:http://link.springer.com/article/10.1186/s13014-020-01609-0

Internet

http://link.springer.com/article/10.1186/s13014-020-01609-0

Similar Items